hot flashes

Cash-strapped Acer sees menopause drug flunk phase 2 trial
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Fierce Biotech
Acer Therapeutics
clinical trials
hot flashes
menopause
osanetant
Flag link:
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
Endpoints
Astellas
hot flashes
menopause
fezolinetant
patient education
Flag link:
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Clinical Trials Arena
Astellas
clinical trials
menopause
China
fezolinetant
vasomotor symptoms
hot flashes
Flag link:
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Astellas
menopause
FDA
clinical trials
Asia
fezolinetant
hot flashes
Flag link:
Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record
Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record
Fierce Biotech
Astellas
menopause
hot flashes
clinical trials
fezolinetant
Flag link:
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Pharmaforum
Astellas
menopause
clinical trials
fezolinetant
hot flashes
Flag link:
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
Fierce Biotech
Mithra
clinical trials
menopause
FDA
hot flashes
Flag link:
Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff
Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff
Endpoints
Astellas
clinical trials
fezolinetant
menopause
hot flashes
Flag link:
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Fierce Biotech
Bayer
KaNDy Therapeutics
M&A
Women's Health
menopause
hot flashes
NT-814
Flag link:
Concept Device Designed to Tame Menopausal Hot Flashes
Concept Device Designed to Tame Menopausal Hot Flashes
Medical Devices and Diagnostics Industry
devices
Cambridge Consultants
hot flashes
menopause
Flag link:
Astellas swoops in on a mid-stage drug for hot flashes in $860M biotech buyout deal
Astellas swoops in on a mid-stage drug for hot flashes in $860M biotech buyout deal
Endpoints
Astellas
hot flashes
M&A
Ogeda
Flag link:
Pfizer: The Menopause Opportunity
Pfizer: The Menopause Opportunity
Seeking Alpha
Pfizer
Duavee
menopause
Ligand Pharmaceuticals
Eli Lilly
Hisamitsu
hot flashes
Flag link:
Did Pfizer and Ligand Just Get a New Winning Drug Approved?
Did Pfizer and Ligand Just Get a New Winning Drug Approved?
Wall St. Cheat Sheet
Pfizer
Ligand
Duavee
hot flashes
menopause
osteoporosis
Flag link:
Pfizer, Ligand Win U.S. Approval for Hot Flash Therapy
Pfizer, Ligand Win U.S. Approval for Hot Flash Therapy
Bloomberg
Pfizer
Ligand
hot flashes
menopause
osteoporosis
FDA
Duavee
Flag link:
Why Ligand Pharmaceuticals Shares Popped
Why Ligand Pharmaceuticals Shares Popped
Motley Fool
Ligand
hot flashes
Brisdelle
Hisamitsu
Pfizer
bazedoxifene
Flag link:
Hisamitsu Wins U.S. Approval for Drug to Ease Hot Flashes
Hisamitsu Wins U.S. Approval for Drug to Ease Hot Flashes
Bloomberg
Hisamitsu
hot flashes
Brisdelle
FDA
Noven
Flag link:
Hot Flash Drugs Fail to Win FDA Advisers’ Support
Hot Flash Drugs Fail to Win FDA Advisers’ Support
Bloomberg
FDA
hot flashes
Noven
menopause
Depomed
Hisamitsu
Sefelsa
Serada
Flag link:
Menopause Drugs from Depomed, Hisamitsu Offer Benefits
Menopause Drugs from Depomed, Hisamitsu Offer Benefits
Bloomberg
Depomed
Hisamitsu
menopause
hot flashes
gabapentin
paroxetine mesylate
Flag link:
Serada Approval Presents Big Upside To Depomed
Serada Approval Presents Big Upside To Depomed
Seeking Alpha
Serada
Depomed
hot flashes
gabapentin
Flag link:
Hot flashes may return after ending Lexapro antidepressant: study
Hot flashes may return after ending Lexapro antidepressant: study
Reuters
Lexapro
hot flashes
antidepressants
Forest Labs
Flag link:

Pages